| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Jonathan Schechter is Director at PMCB and has filed Form 4s across 3 companies. Jonathan Schechter's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $137K at current prices.
Historically, Jonathan Schechter's trades have earned a below-average insider score of 40/100 across 7 rated trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -7.7%.
The biggest single holding is PMCB (~$65K). Net of sales, the PMCB filings show accumulation of 60,000 shares.
Jonathan Schechter has 17 Form 4 filings on record from July 2021 to March 2026, across 3 companies: Director at PharmaCyte Biotech (PMCB), 2023–2026; Director at TaoWeave (TWAV), 2025; Director at TAO Synergies (TAOX), 2021–2025.
The 22 reported transactions were 10 option or other derivative awards, 6 open-market purchases, 3 stock awards and 2 tax withholdings, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 4 purchases worth about $108K and 1 sale worth about $24K.
The largest open-market purchase was 60,000 shares of PMCB at an average $0.80 on January 7, 2026, about $48K.
The only open-market sale was 20,250 shares of TAOX at an average $1.17 on December 16, 2022, about $24K. Twelve months later TAOX was down 77%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 7, 2026 | PMCB Pharmacyte Biotech, Inc. | - | Buy | 60,000 | $0.80 | $48,232.00 | +45.3% | -17.9% | - | |
| Nov 14, 2025 | TWAV Taoweave, Inc. | Director | Buy | 10,000 | $1.91 | $19,100.00 | +66.7% | -53.3% | - | |
| Sep 17, 2025 | TWAV Taoweave, Inc. | Director | Buy | 5,000 | $2.70 | $13,475.50 | +50.0% | -19.1% | -52.0% | |
| Sep 16, 2025 | TWAV Taoweave, Inc. | Director | Buy | 10,000 | $2.73 | $27,321.00 | New | -13.2% | -48.1% | |
| Dec 16, 2022 | TAOX Tao Synergies Inc. | Director | Sell | 20,250 | $1.17 | $23,730.98 | -41.5% | -29.9% | -77.2% |